📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-24 19:02
538 analysed today
FollowTelegram
538
Today
149,939
All-time analysed
42,983
Positive
6,669
Negative
91,579
Neutral
8,640
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
Healthy Life Agritec Board to Meet on Sept 29 to Finalize Up to ₹50 Cr Rights Issue Terms
Healthy Life Agritec has scheduled a Board of Directors meeting for September 29, 2026, to determine the specific terms of its proposed Rights Issue. The company had previously approved raising up to ₹5,000 lakhs (₹50 crore) via partly paid-up equity shares of face value ₹10 each. The proposed fundraise is massive relative to the company's current scale, representing approximately 156% of its market capitalization of ₹32 crore and 85% of its net worth of ₹59 crore. The meeting will decide the issue price, entitlement ratio, record date, and timing, subject to in-principle approval from BSE Limited.
Confidence: HIGH
What changedHealthy Life Agritec called a board meeting for September 29, 2026, to finalize the price, entitlement ratio, and schedule for its ₹50 crore Rights Issue.
Why it mattersA fundraise of ₹50 crore exceeds the company's market cap (₹32 crore) and will lead to substantial equity dilution, but could significantly strengthen its balance sheet if fully subscribed.
Max Rights Issue size: ₹5,000 lakhsIssue size vs Market Cap: ~156%Face value per share: ₹10Board meeting date: September 29, 2026
📅 Short termShare price volatility is likely around the September 29 meeting as markets price in the rights issue discount, entitlement ratio, and record date.
📈 Long termIf successfully raised, the capital will alter the company's capital structure and provide liquidity, but non-participating shareholders face heavy dilution given the issue size relative to market cap.
⚠ Risk flags
- Severe dilution risk given the issue size (₹50 crore) exceeds current market capitalization (₹32 crore)
- Subject to BSE in-principle approval and full shareholder subscription risk
- Promoter holding stands at 28.86%, so promoter participation will be critical
Key Highlights
Board meeting scheduled for September 29, 2026, to decide Rights Issue terms
Total Rights Issue size capped at an amount not exceeding ₹5,000 lakhs (₹50 crore)
Issue structure entails partly paid-up equity shares with a face value of ₹10 each
Proposed ₹50 crore fundraise equals ~156% of the company's current ₹32 crore market capitalization
Implementation remains subject to in-principle approval from BSE Limited
👀 What to Watch
Track the outcome of the September 29 board meeting for the announced rights price, entitlement ratio, and record date to evaluate the level of equity dilution.
Healthy Life Agritec Approves Rights Issue of Up to ₹50 Cr
The Board of Directors of Healthy Life Agritec Ltd has approved fundraising of up to ₹5,000 Lakhs (₹50 Cr) via a rights issue of partly paid-up equity shares with a face value of ₹10 each. The proposed issue size of ₹50 Cr is substantial, representing approximately 156% of the company's current market cap of ₹32 Cr and 85% of its net worth (₹59 Cr). The issue price, rights entitlement ratio, and record date will be finalized later by the newly formed Rights Issue Committee. The rights issue remains subject to necessary statutory and stock exchange approvals.
Confidence: HIGH
What changedThe Board has approved a rights issue proposal to raise up to ₹50 Cr via partly paid equity shares and established a Rights Issue Committee.
Why it mattersA fundraise of ₹50 Cr is massive relative to the firm's ₹32 Cr market cap and will cause heavy equity dilution while significantly restructuring the balance sheet.
Max rights issue amount: ₹5,000 LakhsFace value per share: ₹10Fundraise vs Market Cap: ~156%Fundraise vs Net Worth: ~85%
📅 Short termInvestors will monitor the discount offered via the rights issue price compared to current trading levels and the details of call payments.
📈 Long termIf successfully deployed into core dairy operations or debt reduction, the capital could support scale, but substantial dilution may suppress per-share metrics.
⚠ Risk flags
- Severe equity dilution given the proposed issue size is 1.5x current market capitalization
- Low promoter holding of 28.86% raises questions on full promoter subscription
- Execution risk on calls/payment collection for partly paid-up shares
Key Highlights
Board approved raising funds up to ₹5,000 Lakhs (₹50 Cr) via a Rights Issue
Securities proposed are partly paid-up equity shares of face value ₹10 each
Fundraise amount of ₹50 Cr exceeds the company's current market capitalization of ₹32 Cr (~156%)
Rights Issue Committee formed comprising Divya Mojjada, Mohammed Sadiq, and Apra Sharma
Pricing, entitlement ratio, and record date are yet to be determined
👀 What to Watch
Track subsequent announcements regarding the rights entitlement ratio, issue price, record date, and terms of payment on partly paid shares.
Healthy Life Agritec Approves Rights Issue of Up to ₹50 Cr
The Board of Directors of Healthy Life Agritec Ltd has approved fundraising of up to ₹5,000 Lakhs (₹50 Cr) via a rights issue of partly paid-up equity shares with a face value of ₹10 each. The proposed issue size of ₹50 Cr is substantial, representing approximately 156% of the company's current market cap of ₹32 Cr and 85% of its net worth (₹59 Cr). The issue price, rights entitlement ratio, and record date will be finalized later by the newly formed Rights Issue Committee. The rights issue remains subject to necessary statutory and stock exchange approvals.
Confidence: HIGH
What changedThe Board has approved a rights issue proposal to raise up to ₹50 Cr via partly paid equity shares and established a Rights Issue Committee.
Why it mattersA fundraise of ₹50 Cr is massive relative to the firm's ₹32 Cr market cap and will cause heavy equity dilution while significantly restructuring the balance sheet.
Max rights issue amount: ₹5,000 LakhsFace value per share: ₹10Fundraise vs Market Cap: ~156%Fundraise vs Net Worth: ~85%
📅 Short termInvestors will monitor the discount offered via the rights issue price compared to current trading levels and the details of call payments.
📈 Long termIf successfully deployed into core dairy operations or debt reduction, the capital could support scale, but substantial dilution may suppress per-share metrics.
⚠ Risk flags
- Severe equity dilution given the proposed issue size is 1.5x current market capitalization
- Low promoter holding of 28.86% raises questions on full promoter subscription
- Execution risk on calls/payment collection for partly paid-up shares
Key Highlights
Board approved raising funds up to ₹5,000 Lakhs (₹50 Cr) via a Rights Issue
Securities proposed are partly paid-up equity shares of face value ₹10 each
Fundraise amount of ₹50 Cr exceeds the company's current market capitalization of ₹32 Cr (~156%)
Rights Issue Committee formed comprising Divya Mojjada, Mohammed Sadiq, and Apra Sharma
Pricing, entitlement ratio, and record date are yet to be determined
👀 What to Watch
Track subsequent announcements regarding the rights entitlement ratio, issue price, record date, and terms of payment on partly paid shares.
Q1 FY27 PAT Rises 68% YoY to Rs 1.39 Cr; Revenue Up 63% to Rs 69.52 Cr
Healthy Life Agritec reported a 68.1% YoY increase in consolidated net profit to Rs 1.39 Cr (Rs 139.49 lakhs) for the quarter ended June 30, 2026, compared to Rs 0.83 Cr in Q1 FY26. Consolidated revenue from operations grew 62.6% YoY to Rs 69.52 Cr (Rs 6,952.15 lakhs) from Rs 42.76 Cr, though it declined 18.4% QoQ against Rs 85.19 Cr in Q4 FY26. Basic EPS stood at Rs 0.28 for the quarter, compared to Rs 0.33 in the prior-year period due to the doubling of paid-up equity capital to Rs 49.62 Cr.
Confidence: HIGH
What changedThe company reported its unaudited Q1 FY27 financial results showing strong YoY revenue and profit growth.
Why it mattersDemonstrates strong top-line scale over the prior year, though profitability remains thin as trading purchases account for most operating costs.
Consolidated Revenue (Q1): Rs 6,952.15 lakhsConsolidated PAT (Q1): Rs 139.49 lakhsYoY Revenue Growth: 62.58%YoY PAT Growth: 68.10%Paid-up Equity Capital: Rs 4,962.40 lakhs
📅 Short termLikely to be viewed positively due to strong YoY earnings growth, though sequential revenue moderation may temper enthusiasm.
📈 Long termStructural upside remains constrained by thin net margins (~2%) and dependency on low-margin trading operations unless processing value-add scales.
⚠ Risk flags
- Extremely thin net profit margins (~2%)
- Dilution impact from doubled equity capital base (Rs 49.62 Cr vs Rs 24.81 Cr YoY)
- Low promoter holding at 28.86%
Key Highlights
Consolidated revenue from operations rose 62.6% YoY to Rs 6,952.15 lakhs (Rs 69.52 Cr) from Rs 4,276.33 lakhs in Q1 FY26.
Consolidated PAT increased 68.1% YoY and 32.9% QoQ to Rs 139.49 lakhs (Rs 1.39 Cr) vs Rs 82.98 lakhs in Q1 FY26.
Standalone revenue stood at Rs 2,840.99 lakhs with a standalone PAT of Rs 74.35 lakhs.
Paid-up equity share capital doubled YoY to Rs 4,962.40 lakhs from Rs 2,481.20 lakhs in Q1 FY26.
👀 What to Watch
Track whether the company can maintain quarterly revenue momentum above Rs 70 Cr and sustain operating margins in its core dairy trading business.
Healthy Life Agritec Q1 Cons. PAT Up 68% YoY to ₹1.39 Cr; Revenue Jumps 63% to ₹69.52 Cr
Healthy Life Agritec reported a 68.1% YoY increase in consolidated net profit to ₹1.39 Cr (₹139.49 lakhs) for the quarter ended June 30, 2026, compared to ₹0.83 Cr in Q1 FY26. Consolidated revenue from operations grew 62.6% YoY to ₹69.52 Cr (₹6,952.15 lakhs) compared to ₹42.76 Cr in the prior-year period, though it contracted 18.4% sequentially from ₹85.19 Cr in Q4 FY26. Profit before tax rose 69.9% YoY to ₹1.89 Cr (₹188.78 lakhs) from ₹1.11 Cr in Q1 FY26. Basic and diluted EPS stood at ₹0.28 on an expanded equity share base of ₹49.62 Cr.
Confidence: HIGH
What changedSubmission and board approval of unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026.
Why it mattersDemonstrates robust YoY top-line and bottom-line expansion despite a thin operating margin profile typical of agri-trading businesses.
Consolidated Revenue (Q1 FY27): Rs. 6952.15 lakhsConsolidated Net Profit (Q1 FY27): Rs. 139.49 lakhsConsolidated PBT (Q1 FY27): Rs. 188.78 lakhsPaid up equity capital: Rs. 4962.40 lakhsBasic EPS: Rs. 0.28
📅 Short termLikely positive reaction to the 68% YoY jump in net profit, though sequential revenue moderation from Q4 FY26 may temper gains.
📈 Long termSustained revenue scale and operating profit margin expansion are essential for long-term value creation given inherently low trading margins (~2-3%).
⚠ Risk flags
- Low operating margin profile leaving little buffer against commodity price fluctuations
- Sequential revenue decline of 18.4% QoQ compared to Q4 FY26
Key Highlights
Consolidated revenue from operations rose 62.6% YoY to ₹69.52 Cr (₹6,952.15 lakhs) vs ₹42.76 Cr in Q1 FY26
Consolidated PAT increased 68.1% YoY and 32.9% QoQ to ₹1.39 Cr (₹139.49 lakhs)
Profit Before Tax (PBT) expanded to ₹1.89 Cr (₹188.78 lakhs) vs ₹1.11 Cr in Q1 FY26
Standalone revenue stood at ₹28.41 Cr with standalone net profit of ₹0.74 Cr
Paid-up equity share capital was ₹49.62 Cr (doubled from ₹24.81 Cr in Q1 FY26)
👀 What to Watch
Track whether the strong YoY operational growth and margin expansion can be sustained in subsequent quarters, and watch for working capital management and revenue recovery from the sequential QoQ drop.
